(FOA)-Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional); February 5, 2019

 

Agency:

National Cancer Institute (NCI)

 

Description: The purpose of this engineering-oriented funding opportunity announcement (FOA) is to encourage submissions of Exploratory/Developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility.

 

Activity Code:

R21 Exploratory/Developmental Research Grant   

Announcement Number:

PAR-19-150

 

Closing Date:

February 5, 2019

 

Link to Full Announcement:

http://grants.nih.gov/grants/guide/pa-files/PAR-19-150.html

 

Companion Funding Opportunity:

R21 – http://grants.nih.gov/grants/guide/pa-files/PAR-19-149.html